Page 74 - Sohini Das

Gennova's mRNA vaccine in legal storm after HDT Bio Corp sues Emcure

The US firm HDT Bio Corp has alleged that Emcure 'willfully and maliciously' violated the Defend Trade Secrets Act and Washington's laws against trade secret theft

India reports 19% jump in TB cases in 2021: India TB Report

TB notifications started to pick up towards the end of 2020, and a total of 1.8 mn cases could be notified, an increase of 11%

Two years after Covid, experts in India feel it's right time to 'open' up

Gagandeep Kang, microbiologist and professor at CMC, Vellore says this is the right time to relax Covid curbs, but as long as we also plan for worst case scenarios

Reducing dose gap may help liquidate Covishield vaccine stocks faster

Liquidating stocks is critical for SII as it can store around 600-700 million doses at its site.

Serum Institute seeks Covovax EUA for 7- to 11-year age group

Pune-based vaxmaker conducting trials on children aged 2 yrs and above

Centre asks states to end all Covid containment measures from March 31

Masks and social distancing norms will continue: MHA

No more Covid curbs under Disaster Management Act after March 31: MHA

Masks, social distancing norms to continue; States and UTs allowd to issue standard operating procedures (SoPs) for containment measures, vaccination

World's first ayush phase-3 trial for rheumatoid arthritis in India

Study will begin in May, to take two years to complete

FY22 Healthcare hires saw 100-220% growth in specialised roles: TeamLease

Overall employment in sector grew from 6.8 mn in FY21 to 7.5 mn in FY22; about 9.5 mn people likely to be employed by FY26

Wockhardt, Serum Institute of India tie up to make vaccines in UK

SII has supplied the AstraZeneca-Oxford vaccine to the UK already, and having a fill-and-finish facility in the UK would help the firm to have closer access to the UK and EU markets.

Health technology platform Tata 1mg steps up diagnostics play

Since Tata 1mg is focused on online diagnostics and home collection of samples, it has third-party partners for radiology tests

Cloudnine aims to raise Rs 1,200 crore, add 7 hospitals every year

Cloudnine's revenues increased at a CAGR of 15.16 per cent from Rs 418 crore in FY19 to Rs 554 crore in FY21, while its Ebitda increased at a CAGR of 55.8 per cent

TRIPS waiver may have little impact, say Indian vaccine makers

Vaccine industry insiders feel intellectual property rights is not the only or main obstacle to ensure higher access of Covid-19 vaccine

Now, Manipal Hospitals to monitor patients post discharge through Fitbit

Manipal Hospitals said that the service would be voluntary for its patients and offered free of cost for the time-being

19 Indian companies sign licensing pact for Pfizer's oral Covid drug

Torrent Pharma and Cadila Pharma sign licensing agreement with MPP to make and market the drug

Slow start to coronavirus vaccination drive for 12-14-year age group

The upcoming Holi weekend could also to be a dampener for the drive

Biological E prices Corbevax at Rs 800 a dose, plans 100 mn shots

Plans to test vaccine on six-month old infants; seeks EUA for 5- to 12-yr-old children

SII seeks inclusion of Covovax in Govt vax drive for 12 yr and above

Registrations for 12-14 year olds on Co-Win will begin from Wednesday

Covid-19 vaccination drive: 12-14-year-olds to get Corbevax shots

Union Health Ministry also opened up vaccination for all those above 60 years, removes the precondition of co-morbidity

Will India go for mixing vaccines for booster shot? Decision soon

A third shot that does not match the first two doses may be allowed